- Home
- VPV vs DERM Comparison
VPV vs DERM Comparison
Compare VPV & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VPV
- DERM
- Stock Information
- Founded
- VPV 1993
- DERM 2014
- Country
- VPV United States
- DERM United States
- Employees
- VPV N/A
- DERM N/A
- Industry
- VPV Trusts Except Educational Religious and Charitable
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- VPV Finance
- DERM Health Care
- Exchange
- VPV Nasdaq
- DERM Nasdaq
- Market Cap
- VPV 183.2M
- DERM 190.7M
- IPO Year
- VPV N/A
- DERM 2021
- Fundamental
- Price
- VPV $10.34
- DERM $7.54
- Analyst Decision
- VPV
- DERM Strong Buy
- Analyst Count
- VPV 0
- DERM 3
- Target Price
- VPV N/A
- DERM $12.67
- AVG Volume (30 Days)
- VPV 36.6K
- DERM 92.2K
- Earning Date
- VPV 01-01-0001
- DERM 11-11-2025
- Dividend Yield
- VPV 3.60%
- DERM N/A
- EPS Growth
- VPV N/A
- DERM N/A
- EPS
- VPV N/A
- DERM N/A
- Revenue
- VPV N/A
- DERM $56,397,000.00
- Revenue This Year
- VPV N/A
- DERM $26.25
- Revenue Next Year
- VPV N/A
- DERM $52.96
- P/E Ratio
- VPV N/A
- DERM N/A
- Revenue Growth
- VPV N/A
- DERM N/A
- 52 Week Low
- VPV $8.58
- DERM $3.54
- 52 Week High
- VPV $10.28
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- VPV 53.36
- DERM 59.93
- Support Level
- VPV $10.31
- DERM $6.85
- Resistance Level
- VPV $10.49
- DERM $7.45
- Average True Range (ATR)
- VPV 0.11
- DERM 0.30
- MACD
- VPV -0.02
- DERM 0.04
- Stochastic Oscillator
- VPV 13.57
- DERM 100.00
About VPV Invesco Pennsylvania Value Municipal Income Trust (DE)
Invesco Pennsylvania Value Municipal Income Trust is a diversified, closed-end management investment company. The investment objective is to provide common shareholders with a high level of current income exempt from federal and Pennsylvania income taxes and, where possible under local law, local income and personal property taxes, consistent with preservation of capital.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.